☆ 4.5 Article

Effectiveness of Spironolactone in Terms of Galectin-3 Levels in Patients with Heart Failure with a Reduced Ejection Fraction in the Vietnamese Population

HEALTHCARE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Pharmacology & Pharmacy

Effect of Mineralocorticoid Receptor Antagonists in Heart Failure with Preserved Ejection Fraction and with Reduced Ejection Fraction - A Nar-rative Review

Adriana Mares et al.

Summary: This narrative review evaluates the benefits, potential risks, and role of Mineralocorticoid Receptor Antagonists (MRAs) in the management of Heart Failure with Preserved Ejection Fraction (HFpEF) and Heart Failure with Reduced Ejection Fraction (HFrEF). Clinical evidence shows that MRAs can reduce mortality and readmissions for HFrEF patients and reduce heart failure hospitalizations for HFpEF patients. However, MRAs are underutilized in the management of heart failure.

CURRENT VASCULAR PHARMACOLOGY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Prediabetes and insulin resistance in a population of patients with heart failure and reduced or preserved ejection fraction but without diabetes, overweight or hypertension

Tran Kim Son et al.

Summary: This study investigated the prevalence of prediabetes and insulin resistance (IR) in Vietnamese patients with heart failure (HF) and no overweight, diabetes, or hypertension. The study found that HF patients had a higher prevalence of prediabetes and IR compared to healthy controls. Furthermore, prediabetes and IR were associated with a more severe HF. These findings suggest that HF may play a role in the development of IR and emphasize the importance of intervention strategies for HF patients with prediabetes.

CARDIOVASCULAR DIABETOLOGY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Obesity, Galectin-3, and Incident Heart Failure: The ARIC Study

Roberta Florido et al.

Summary: This study found a strong association between obesity and galectin-3, a biomarker of cardiac inflammation and fibrosis. The combination of obesity and elevated galectin-3 is associated with a significantly increased risk of heart failure.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Safety and effectiveness of angiotensin receptor-neprilysin inhibitors in patients with heart failure with preserved ejection fraction (ARNI-PRESERVED study)

PVJ Jariwala et al.

European Heart Journal-Acute Cardiovascular Care (2022)

添加到收藏夹

Article Endocrinology & Metabolism

Obesity in Older Adults and Associations with Cardiovascular Structure and Function

Yen How Tan et al.

Summary: This study aimed to investigate the associations between BMI and WC with cardiovascular structure and function in older adults. The results showed that WC was a more effective indicator of abdominal adiposity and had stronger correlations with impaired myocardial relaxation (E/A), aerobic capacity, and left atrial structure compared to BMI.

OBESITY FACTS (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction EMPEROR-Preserved Trial

Milton Packer et al.

Summary: Empagliflozin significantly reduced the risk of heart failure-related inpatient and outpatient events in patients with heart failure with preserved ejection fraction, including cardiovascular death, heart failure hospitalization, and urgent visits, while also decreasing total heart failure hospitalizations and intensive care admissions. Patients receiving empagliflozin may experience improved New York Heart Association functional class levels.

CIRCULATION (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Theresa A. McDonagh et al.

EUROPEAN HEART JOURNAL (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Galectin-3 in Cardiovascular Diseases

Valeria Blanda et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Galectin-3 and Arterial Stiffness in Patients with Heart Failure: A Pilot Study

Evangelos Oikonomou et al.

CURRENT VASCULAR PHARMACOLOGY (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Inflammation and insulin resistance: New targets encourage new thinking

Andrew M. F. Johnson et al.

BIOESSAYS (2017)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Piotr Ponikowski et al.

EUROPEAN HEART JOURNAL (2016)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

NT-proBNP The Gold Standard Biomarker in Heart Failure

Paul M. Mckie et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Prognostic value of NT-proBNP in heart failure with preserved versus reduced EF

Si-Hyuck Kang et al.

HEART (2015)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Mineralocorticoid Receptor Antagonists Modulate Galectin-3 and Interleukin-33/ST2 Signaling in Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction

Antonio Lax et al.

JACC-HEART FAILURE (2015)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial

Frank Edelmann et al.

EUROPEAN JOURNAL OF HEART FAILURE (2015)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure

Mark Oremus et al.

HEART FAILURE REVIEWS (2014)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

The Global Health and Economic Burden of Hospitalizations for Heart Failure Lessons Learned From Hospitalized Heart Failure Registries

Andrew P. Ambrosy et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Galectin-3: A new biomarker for the diagnosis, analysis and prognosis of acute and chronic heart failure

Nataliya Hrynchyshyn et al.

ARCHIVES OF CARDIOVASCULAR DISEASES (2013)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Galectin-3 in Ambulatory Patients With Heart Failure Results From the HF-ACTION Study

G. Michael Felker et al.

CIRCULATION-HEART FAILURE (2012)

添加到收藏夹

Article Medicine, General & Internal

The fibrosis marker galectin-3 and outcome in the general population

R. A. de Boer et al.

JOURNAL OF INTERNAL MEDICINE (2012)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community

Jennifer E. Ho et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)

添加到收藏夹

Article Medicine, General & Internal

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction

Rudolf A. de Boer et al.

ANNALS OF MEDICINE (2011)

添加到收藏夹

Article Immunology

GALECTIN-3 PLASMA LEVELS AND CORONARY ARTERY DISEASE: A NEW POSSIBLE BIOMARKER OF ACUTE CORONARY SYNDROME

C. Falcone et al.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2011)

添加到收藏夹

Article Medical Laboratory Technology

Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure

Robert H. Christenson et al.

CLINICAL BIOCHEMISTRY (2010)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Inflammation increases NT-proBNP and the NT-proBNP/BNP ratio

Juliana Jensen et al.

CLINICAL RESEARCH IN CARDIOLOGY (2010)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study

Dirk J. A. Lok et al.

CLINICAL RESEARCH IN CARDIOLOGY (2010)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure

Ravi V. Shah et al.

EUROPEAN JOURNAL OF HEART FAILURE (2010)

添加到收藏夹

Review Medicine, General & Internal

Adiposity of the heart*, revisited

JM McGavock et al.

ANNALS OF INTERNAL MEDICINE (2006)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients

JL Januzzi et al.

EUROPEAN HEART JOURNAL (2006)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure

F Gustafsson et al.

JOURNAL OF CARDIAC FAILURE (2005)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

NT-ProBNP: The mechanism behind the marker

C Hall

JOURNAL OF CARDIAC FAILURE (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.